Being at the forefront of technology takes courage, perseverance, knowledge and experts guiding you to lead the change.

Our services


News


Inveniam’s commitment to ESG

Inveniam intends to take up this challagence by offering a quality service for the efficient assessment, measurement and integration of ESG criteria in the analysis of investments, transforming financial information into financial-social information.

Cellular immunotherapy to cope with Covid-19

At Inveniam Group, we would like to congratulate Dr. Rafael Correa Rocha, head of the Immune-Regulation Laboratory of Gregorio Marañón Hospital, for participating in a European consortium that promotes research on cellular immunotherapies to cope with Covid-19. The consortium is coordinated by the Hospital Clínic de Barcelona – IDIBAPS with support of the company Cellnex…

Time is Brain news article

Time is Brain is developing a new class medical device to improve the diagnosis, treatment, and follow-up of the patient with acutre ischemic stroke.

Projects


Fuel Save

Germany

Inveniam supported the company in winning an Blue Invest

Public Funding from EU

Public Funding 2020

Time is Brain

Spain

Inveniam supported the company in winning an EIT Health Headstart

Public Funding from EU

Public Funding 2020

Miwendo

Spain

Inveniam supported the company in winning an EIC Accelerator grant

Public Funding from EU

Public Funding 2020

Pharmacelera

Spain

Inveniam supported the company in winning an EIC Accelerator grant

Public Funding from EU

Public Funding 2020

Socrates Consortium

Spain

Inveniam supported in the presentation for the Interactive Technologies call

Public Funding from EU

Public Funding 2020

Devicare

Spain

Inveniam advised in the Series A round closing a deal with Successful Ventures

Equity Fundraising

Financial Services & Transaction Advisory 2020

TedCas

Spain

Inveniam advised the company in a seed round with business angels

Equity Fundraising

Financial Services & Transaction Advisory 2019

Símbiosy

Spain

Inveniam supported the company in winning the SME Instrument Phase I

Public Funding from EU

Public Funding 2019